1/21
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Risk Factor
Confirmed causal relationship with periodontitis, e.g., smoking, diabetes.
Risk Determinant
Non-modifiable factors influencing periodontitis, e.g., age, genetics.
Risk Indicator
Likely association with periodontitis, e.g., stress, osteoporosis.
Risk Predictor
Associated with disease progression but not causative in periodontitis.
Periodontitis
A severe gum disease characterized by inflammation and tissue loss.
BOP
Bleeding on Probing; a clinical sign of periodontal disease.
PD
Probing Depth; measurement used to assess periodontal health.
CAL
Clinical Attachment Loss; loss of connective tissue attachment.
Supportive Periodontal Therapy (SPT)
Ongoing maintenance treatment to prevent disease recurrence.
Necrotizing Periodontal Diseases (NPDs)
A group of severe periodontal diseases, including NUG and NUP.
Systemic Diseases Linked to Periodontitis
Diseases such as diabetes, cardiovascular disease, and respiratory diseases that relate to periodontal health.
Scaling and Root Planing (SRP)
A non-surgical procedure aimed at removing plaque and calculus for periodontal therapy.
Epidemiology of Periodontitis
47.2% of US adults are affected; prevalence increases with age.
Preliminary Phase
The initial phase of periodontal treatment focusing on urgent care.
Surgical Therapy
Intervention required when non-surgical therapy fails.
Major Modifiable Risk Factors
Factors like smoking, diabetes, and obesity that can be changed to improve periodontal health.
Clinical Signs of Periodontal Abscess
Localized pain, swelling, deep pockets with pus, and possible tooth mobility.
Diagnostic Features of NPDs
Punched-out papillae, severe pain, gray pseudomembrane, and malodor.
Treatment Protocol for NPDs
Includes debridement, systemic antibiotics, and lifestyle modifications.
Expected Time Frame for Re-evaluation
4-6 weeks after SRP for periodontitis assessment.
Goal of Phase 1 Therapy
Control infection and reduce inflammation through SRP and OHI.
Frequency of Supportive Periodontal Therapy
Every 3-4 months based on individual risk assessment.